Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Metadata
Title
A New In Vitro Blood Hyperviscosity Model
Authors
A. V. Sidekhmenova
O. I. Aliev
N. S. Domnina
P. S. Vlasov
E. V. Popova
M. B. Plotnikov
Publication date
01-02-2022
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 4/2022
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-022-05423-4

Other articles of this Issue 4/2022

Bulletin of Experimental Biology and Medicine 4/2022 Go to the issue

BIOTECHNOLOGIES

New Carbon-Mineral Sorbent Based on Aluminum Oxide, Polydimethylsiloxane, and Single-Wall Carbon Nanotubes: Assessment of the Effect on Erythrocytes In Vitro

ECOLOGY

Reproductive Function of Male Rats and Motor Activity of Their Offspring in Fire Emissions Modeling

OriginalPaper

Delayed Consequences of Experimental Myocardial Infarction: Functional Responses to Stimulation of α2-Adrenoreceptors in the Isolated Heart

OriginalPaper

Diffusional Characteristics of Brain Matter after Stroke

ONCOLOGY

The Role of Redox Status Changes in Dexamethasone-Induced Apoptosis in Jurkat Tumor Cells

OriginalPaper

Anti-Inflammatory and Anti-Oxidant Activity of Ultra-Short Wave Diathermy on LPS-Induced Rat Lung Injury

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits